Wednesday, November 24, 2021 9:38:06 AM
I understand that a similar tote from a previous (2018) SNO was reported here. IMO there are two very big differences between then and now. First, the registered trademark symbol is missing from 2018. Second, NWBO had an active trial open in 2018 and they do not anymore as of 10.5.2020. Before anyone jumps on the UCLA combo trial, it is just that a trial sponsored by LL and the UCLA, not NWBO. There are no active US trials sponsored by NWBO..
Also, regulatory scrutiny over premarket practices dramatically increases once you initiate the process towards approval. If the BLA is rolling, my opinion would be that started when the database was locked. If this is a more standard submission, then it may be that nothing at all has been filed and fear of reprisal remains low.
A question for Senti and others…if DCVax-l (or its alternative name DCVax) is a platform technology and not a vaccine drug therapy, then what exactly is the drug? It seems to me that each individual batch is unique, so it can’t be at the batch level or that would require 6.5 billion BLAs to treat everyone on this earth or 325 million BLAs if we focus on the US market. Not sure how you would test efficacy in each of those, or recover a fee for delivery of the product. Recall also that the ABTA ad says Brain Tumor on the page so, I believe that clarifies which version of the process they are referring to when they call themselves an immune therapy. To laymen, lung cancer is lung cancer it does not matter what cell type and brain tumors are brain tumors.
I have a lot of angst about all of this too. As with all legal arguments, it is subject to interpretation. But unlike most legal situations, it is not a judge or jury of peers that decides. It is FDA.
Now, I must go and may not read a single post until Sunday evening.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM